[Federal Register Volume 87, Number 243 (Tuesday, December 20, 2022)]
[Notices]
[Pages 77842-77843]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-27508]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-23-1215; Docket No. CDC-2022-0142]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled Awardee Lead Profile Assessment 
(ALPA). The ICR includes a survey to collect information to identify 
jurisdictional legal frameworks governing funded childhood lead 
poisoning prevention programs and strategies for implementing childhood 
lead poisoning prevention activities in the United States.

DATES: CDC must receive written comments on or before February 21, 
2023.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0142 by either of the following methods:
     Federal eRulemaking Portal: www.regulations.gov. Follow 
the instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road, 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to www.regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (www.regulations.gov) or by U.S. mail to the address listed 
above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7118; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA)(44 U.S.C. 3501-3520), federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    Awardee Lead Profile Assessment (ALPA) (OMB Control No. 0920-1215, 
Exp. Date 03/31/2024)--Revision--National Center for Environmental 
Health (NCEH), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    The Centers for Disease Control and Prevention (CDC) is requesting 
a three-year Paperwork Reduction Act (PRA) clearance for a Revision of 
an

[[Page 77843]]

information collection request (ICR) titled ``Awardee Lead Profile 
Assessment (ALPA)'' (OMB Control No. 0920-1215; Exp. Date 03/31/2024). 
The goal of this ICR is to build on the CDC's existing childhood lead 
poisoning prevention program. CDC requires that ongoing and new CDC 
Childhood Lead Poisoning Prevention Programs (CLPPPs), including the 
FY21 ``Childhood Lead Poisoning Prevention and Surveillance of Blood 
Lead Levels in Children'' (CDC-RFA-EH21-2102), complete the ALPA 
annually. This annual information collection will be used to identify 
jurisdictional legal frameworks governing CDC-funded childhood lead 
poisoning programs (CLPPPs) in the United States and strategies for 
implementing childhood lead poisoning prevention activities. CDC will 
use this information to inform guidance, resource development, and 
technical assistance activities in support of the ultimate goal, which 
is eliminating lead exposure in children. The dissemination of these 
ALPA results will ensure that both funded and non-funded jurisdictions 
are able to: (1) identify policies and other factors that support or 
hinder childhood lead poisoning prevention efforts; (2) understand what 
strategies are being used by funded public health agencies to implement 
childhood lead poisoning prevention activities; and (3) use this 
knowledge to develop and apply similar strategies to support the 
national agenda to eliminate childhood lead poisoning.
    CDC will now use one data collection mode, a web survey. Reporting 
via email will be eliminated. This program management survey has been 
revised in several ways, including the addition of new answer options 
and questions to understand usage of the updated blood lead reference 
value (BLRV). The time per response is the same from the 2021 estimate 
(47 minutes per response) despite revisions to the survey. This updated 
estimate is based on recent pilot tests of the revised survey among 
nine respondents, and includes the time needed to review the ALPA 
Training Manual.
    CDC is requesting OMB approval for a total time burden of 59 hours 
and a total number of 75 respondents per year. These estimates remain 
unchanged from the previous PRA clearance.

                                                            Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                             Number of    Average burden
               Type of respondent                               Form name                    Number of     responses per   per  response   Total burden
                                                                                            respondents     respondent      (in hours)         hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
State or Local Governments (or their bona fide   ALPA Web Survey........................              75               1           47/60              59
 fiscal agents).
                                                                                         ---------------------------------------------------------------
    Total......................................  .......................................  ..............  ..............  ..............              59
--------------------------------------------------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-27508 Filed 12-19-22; 8:45 am]
BILLING CODE 4163-18-P